ATE499383T1 - Eine methode zur herstellung von menschlichem natürlichem interferon-alpha - Google Patents

Eine methode zur herstellung von menschlichem natürlichem interferon-alpha

Info

Publication number
ATE499383T1
ATE499383T1 AT00981122T AT00981122T ATE499383T1 AT E499383 T1 ATE499383 T1 AT E499383T1 AT 00981122 T AT00981122 T AT 00981122T AT 00981122 T AT00981122 T AT 00981122T AT E499383 T1 ATE499383 T1 AT E499383T1
Authority
AT
Austria
Prior art keywords
producing human
human natural
natural interferon
interferon alpha
alpha
Prior art date
Application number
AT00981122T
Other languages
English (en)
Inventor
Real Lemieux
Sonia Neron
Chantal Proulx
Original Assignee
Hema Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hema Quebec filed Critical Hema Quebec
Application granted granted Critical
Publication of ATE499383T1 publication Critical patent/ATE499383T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00981122T 1999-12-13 2000-12-12 Eine methode zur herstellung von menschlichem natürlichem interferon-alpha ATE499383T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17035499P 1999-12-13 1999-12-13
US09/612,583 US6472208B1 (en) 1999-12-13 2000-07-07 Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
PCT/CA2000/001479 WO2001044490A2 (en) 1999-12-13 2000-12-12 A NOVEL METHOD TO PRODUCE HUMAN NATURAL INTERFERON-$g(a)

Publications (1)

Publication Number Publication Date
ATE499383T1 true ATE499383T1 (de) 2011-03-15

Family

ID=26866008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981122T ATE499383T1 (de) 1999-12-13 2000-12-12 Eine methode zur herstellung von menschlichem natürlichem interferon-alpha

Country Status (6)

Country Link
US (1) US6472208B1 (de)
EP (1) EP1237920B1 (de)
AT (1) ATE499383T1 (de)
AU (1) AU1848401A (de)
DE (1) DE60045663D1 (de)
WO (1) WO2001044490A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660523B2 (en) * 2000-09-21 2003-12-09 Schering Corporation Dendritic cells; methods
WO2005042737A1 (ja) * 2003-11-04 2005-05-12 Dnavec Research Inc. 遺伝子導入された樹状細胞の製造方法
WO2006001120A1 (ja) * 2004-06-24 2006-01-05 Dnavec Research Inc. マイナス鎖rnaウイルスを含む抗癌剤
CN111109248A (zh) * 2019-12-24 2020-05-08 武汉博士德生物工程有限公司 一种杂交瘤细胞冻存液及96孔板冻存复苏方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US6288030B1 (en) * 1993-12-22 2001-09-11 Amgen Inc. Stem cell factor formulations and methods
HU222980B1 (hu) * 1998-03-13 2004-01-28 Acapi, Alpha-Chem Advanced Pharmaceutical Industries S.A.E. Eljárás humán Alfa-interferon előállítására

Also Published As

Publication number Publication date
WO2001044490A2 (en) 2001-06-21
EP1237920B1 (de) 2011-02-23
DE60045663D1 (de) 2011-04-07
US6472208B1 (en) 2002-10-29
WO2001044490A3 (en) 2001-11-29
EP1237920A2 (de) 2002-09-11
AU1848401A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
BG108492A (bg) Използване на въглероден окис за подобряване на резултатите при трансплантация на тъкани и органи и потискане на апоптозата
DE60029566D1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
ATE252639T1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
DE59006880D1 (de) Gerät zur Herstellung von Formkörpern und Verwendung desselben zur Herstellung von Inlays, Onlays, und Kronen in der Zahnmedizin.
DE69010276D1 (de) Methode zur Herstellung von hydrophilem-hydrophobem Copolymer-Pulver.
BR9910251A (pt) Estimulação hematopoiética
DE60110342D1 (de) Alpha-Interferon enthaltende Hautpflegemittel
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
ATE478941T1 (de) Vorläuferzellen aus der wharton sulze von humanen nabelschnüren
DE68905939D1 (de) Infektionsresistente zusammensetzungen, medizinische geraete und oberflaechen und verfahren zur herstellung und gebrauch derselben.
DE59006779D1 (de) Medizinische, insbesondere zahnmedizinische Einrichtung.
DE69729864D1 (de) Herstellung von laktamen aus aliphatischen alpha, omega-dinitrilen
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
ES2062887T3 (es) Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.
ATE512668T1 (de) Allogenes tumortherapeutikum
DE60126933D1 (de) Verfahren zur fermentativen herstellung von l-threonine
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
ATE372336T1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
DE60005381D1 (de) Merkzeichnensystem
ATE310747T1 (de) Impfstoff gegen geflügelkokzidose
ATE499383T1 (de) Eine methode zur herstellung von menschlichem natürlichem interferon-alpha
ATE424217T1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
NO20003146L (no) Ketonperoksyd-derivater, deres fremstilling og anvendelse
DK0939769T3 (da) Vertebrat-Smoothened-proteiner

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties